MI Maven Income and Growth VCT 4 PLC Stock: price and directors' dealings · United Kingdom · RNS (LSE)Track the Maven Income and Growth VCT 4 PLC share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are quoted on the UK market, under the supervision of RNS (LSE). Operating in the Finance & Banking sector, Maven Income and Growth VCT 4 PLC has published 22 reports. Market capitalisation: €63.7m. The latest transaction was disclosed on 28 August 2026 (Purchase). Among the most active insiders: Fraser Gray. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,630 of 29,064 companies
FCF yld -1.1%
Earn yld 2.0%
EV/EBITDA ·
ROE 0.6%
Gross mgn ·
Net mgn 73%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
All Executives22 Thresholds0 Prospectus0 Other0
Declarations 22 total
● Director · Executives · 28 Aug 2026
5,640 shares @ £50.45 LondonRNS:9745681 ● Director · Executives · 15 May 2026
2,135 shares @ £0.5272 0.0015% mcap 0.8% of flow LondonRNS:a40f46ed-4914-4b1f-acc1-59996ebaf581 ● Director · Executives · 15 May 2026
2,135 shares @ £0.5272 100.0% of flow LondonRNS:9571050 ● Director · Executives · 17 Feb 2026
184,877 shares @ £0.5409 39.1% of flow LondonRNS:a27a2d58-da6e-4cc0-92ba-dcd408d23b0b ● Spouse of William Robert Nixon, Director · Executives · 17 Feb 2026
184,877 shares @ £0.5409 56.2% of flow LondonRNS:b9a23fdd-55eb-491d-b771-2c13196bfb5d ● Director · Executives · 16 Jan 2026
3,236 shares @ £0.5409 1.2% of flow LondonRNS:1368663f-7a71-4a73-b63f-0f4423bb4508 ● Director · Executives · 15 Jan 2026
9,243 shares @ £0.5409 3.5% of flow LondonRNS:692532ab-21f0-49a8-94bb-18112bbd4817 ● Director · Executives · 15 Jan 2026
23,109 shares @ £0.5409 61.6% of flow LondonRNS:da3d7d1c-5891-4fa1-8cc6-6e7a11f2373b ● Director · Executives · 29 Aug 2025
8,489 shares @ £0.5397 3.3% of flow LondonRNS:5798574 ● Director · Executives · 16 May 2025
4,954 shares @ £0.571 2.2% of flow LondonRNS:5657640 ● Director · Executives · 27 Mar 2025
12,611 shares @ £0.5947 100.0% of flow LondonRNS:5592970 ● Director · Executives · 19 Feb 2025
8,407 shares @ £0.5947 4.0% of flow LondonRNS:5544551 ● Spouse of William Robert Nixon, Director · Executives · 19 Feb 2025
84,076 shares @ £0.5947 67.4% of flow LondonRNS:5544545 ● Director · Executives · 19 Feb 2025
168,152 shares @ £0.5947 67.5% of flow LondonRNS:5544543 ● Director · Executives · 18 Oct 2024
4,927 shares @ £0.6019 2.5% of flow LondonRNS:5395255 ● Director · Executives · 24 May 2024
4,197 shares @ £0.6009 2.1% of flow LondonRNS:5197480 ● Spouse of William Robert Nixon, Director · Executives · 5 Apr 2024
40,512 shares @ £0.6171 100.0% of flow LondonRNS:5132455 ● Director · Executives · 8 Feb 2024
8,103 shares @ £0.6171 4.3% of flow LondonRNS:5061163 ● Director · Executives · 17 Jan 2024
16,207 shares @ £0.617 100.0% of flow LondonRNS:5036007 ● Director · Executives · 17 Jan 2024
81,037 shares @ £0.617 100.0% of flow LondonRNS:5035999 ● Director · Executives · 13 Oct 2023
3,666 shares @ £0.6317 2.0% of flow LondonRNS:4936118 ● Director · Executives · 2 Jun 2023
148,961 shares @ £0.6713 100.0% of flow LondonRNS:4790346 关于 Maven Income and Growth VCT 4 PLC Maven Income and Growth VCT 4 PLC是一家在英国伦敦证券交易所(FTSE 100/250/AIM)上市的英国风险资本信托基金。它不是一家传统的银行或保险公司;相反,它是一种上市的私募股权式工具,旨在通过支持增长型小型企业,为投资者提供长期资本增值和收入。其投资使命是建立一个多元化的合格英国投资组合,核心重点是小型非上市公司,并选择性地投资于AIM上市公司。该战略以识别具有可扩展商业模式的公司、在增长阶段支持管理团队以及通过成功退出实现价值为中心。([mavencp.com](https://www.mavencp.com/hubfs/MIG%204%20Annual%20Report%20YE%2031%20Dec%202024%20%283%29_web.pdf))
该公司于2004年8月26日成立。随着时间的推移,它通过一系列公司合并和名称变更而发展:它曾是Aberdeen Growth Opportunities VCT 2 PLC,后来合并了Maven Income and Growth VCT 6 PLC、Maven Income and Growth VCT 2 PLC、Ortus VCT PLC和Gateway VCT PLC。这段历史突显了其作为成熟、整合的VCT特许经营权而非初创投资工具的地位。其注册办事处位于苏格兰格拉斯哥,地址是Kintyre House, 205 West George Street, Glasgow, G2 2LW。([mavencp.com](https://www.mavencp.com/investment-opportunities/venture-capital-trusts/maven-income-and-growth-vct-4))
在运营方面,Maven VCT 4主要投资于具有增长潜力的小型英国非上市公司和精选的AIM公司。投资组合多元化,涵盖广泛的行业,考虑到小型非上市公司资产固有的较高风险和较低流动性,这一点很重要。2024年年度报告解释说,董事会负责监督结构化的选择、监控和实现过程,而管理人则获得FCA授权,负责寻找和管理投资。在竞争方面,该信托受益于Maven在英国的区域办事处网络及其在中小企业投资方面的长期专业知识,使其能够获得广泛的区域机会渠道,并在支持创业企业方面拥有良好记录。Maven本身成立于2009年,是在Aberdeen Asset Management的私募股权业务管理层收购后成立的,此后已发展成为英国最活跃的中小企业投资者之一。([mavencp.com](https://www.mavencp.com/hubfs/MIG%204%20Annual%20Report%20YE%2031%20Dec%202024%20%283%29_web.pdf))
近期发展强化了公司积极的投资形象。2025年1月,Maven Income and Growth VCTs的更广泛系列启动了超额配售权,将筹资能力扩大到40 million英镑,以应对强劲的投资者需求。2025年12月,Maven VCTs宣布初步投资1.5 million英镑于FITR,这是一个总部位于伦敦的健康科技平台,服务于健身教练和专业人士。该信托还继续发布常规RNS披露,包括PDMR和董事持股通知,反映了上市英国工具应有的治理纪律。([mavencp.com](https://www.mavencp.com/latest-news/maven-vcts-announce-activation-of-20m-vct-over-allotment-facilities))